Professur für Innere Medizin mit dem Schwerpunkt Immundefizienz

Ulmenweg 18
91054 Erlangen

Publications (Download BibTeX)

Go to first page Go to previous page 1 of 2 Go to next page Go to last page

Lee, J.H., Ostalecki, C., Zhao, Z., Kesti, T., Bruns, H., Simon, B.,... Baur, A.S. (2018). HIV Activates the Tyrosine Kinase Hck to Secrete ADAM Protease-Containing Extracellular Vesicles. EBioMedicine.
Hecht, M., Harrer, T., Koeber, V., Sarpong, E.O., Moser, F., Fiebig, N.,... Distel, L. (2018). Cytotoxic effect of Efavirenz in BxPC-3 pancreatic cancer cells is based on oxidative stress and is synergistic with ionizing radiation. Oncology Letters, 15(2), 1728-1736.
Hahn, J., Kienhofer, D., Stoof, J., Csepregi, J.Z., Reinwald, C., Maueröder, C.,... Hoffmann, M. (2017). ROS is the boss. (pp. S17-S17).
Kienhofer, D., Hahn, J., Stoof, J., Csepregi, J.Z., Reinwald, C., Urbonaviciute, V.,... Hoffmann, M. (2017). Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps. JCI Insight, 2(10).
Lankes, K., Hundorfean, G., Harrer, T., Pommer, A.J., Agaimy, A., Angelovska, I.,... Heinzerling, L. (2016). Anti-TNF-refractory colitis after checkpoint inhibitor therapy: Possible role of CMV-mediated immunopathogenesis. OncoImmunology, 5(6), e1128611.
Faetkenheuer, G., Jessen, H., Stoehr, A., Jung, N., Jessen, A.B., Kuemmerle, T.,... Ranneberg, B. (2016). PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis. HIV Medicine, 17(6), 453-9.
Dinges, W., Girard, P.-M., Podzamczer, D., Brockmeyer, N.H., Garcia, F., Harrer, T.,... Roman, F. (2016). The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial. Medicine, 95(6), e2673.
Lee, J.-H., Schierer, S., Blume, K., Dindorf, J., Wittki, S., Xiang, W.,... Baur, A. (2016). HIV-Nef and ADAM17-Containing Plasma Extracellular Vesicles Induce and Correlate with Immune Pathogenesis in Chronic HIV Infection. EBioMedicine, 6, 103-13.
Jackson, C.C., Best, L., Lorenzo, L., Casanova, J.-L., Wacker, J., Bertz, S.,... Harrer, T. (2016). A Multiplex Kindred with Hennekam Syndrome due to Homozygosity for a CCBE1 Mutation that does not Prevent Protein Expression. Journal of Clinical Immunology, 36(1), 19-27.
Ostalecki, C., Wittki, S., Lee, J.-H., Geist, M.M., Tibroni, N., Harrer, T.,... Baur, A. (2016). HIV Nef- and Notch1-dependent Endocytosis of ADAM17 Induces Vesicular TNF Secretion in Chronic HIV Infection. EBioMedicine, 13, 294-304.
Mummert, C., Hofmann, C., Hueckelhoven, A.G., Bergmann, S., Müller-Schmucker, S., Harrer, E.G.,... Harrer, T. (2016). Sequence-function analysis of three T cell receptors targeting the HIV-1 p17. (pp. -).
Wedmann, R., Onderka, C., Wei, S., Szijarto, I.A., Miljkovic, J., Mitrovic, A.,... Filipovic, M. (2016). Improved tag-switch method reveals that thioredoxin acts as depersulfidase and controls the intracellular levels of protein persulfidation. Chemical Science, 7(5), 3414-3426.
Borte, M., Krivan, G., Derfalvi, B., Marodi, L., Harrer, T., Jolles, S.,... Yel, L. (2016). Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies. Clinical and Experimental Immunology.
Mummert, C., Hofmann, C., Hueckelhoven, A.G., Bergmann, S., Mueller-Schmucker, S.M., Harrer, E.G.,... Harrer, T. (2016). T-cell receptor transfer for boosting HIV-1-specific T-cell immunity in HIV-1-infected patients. Aids, 30(14), 2149-58.
Hecht, M., Erber, S., Harrer, T., Klinker, H., Roth, T., Parsch, H.,... Distel, L. (2015). Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells. PLoS ONE, 10(6), e0130277.
Uslu, U., Agaimy, A., Hundorfean, G., Harrer, T., Schuler, G., & Heinzerling, L. (2015). Autoimmune Colitis and Subsequent CMV-induced Hepatitis After Treatment With Ipilimumab. Journal of Immunotherapy, 38(5), 212-5.
Stoll, A., Bergmann, S., Mummert, C., Mueller-Schmucker, S.M., Spriewald, B.M., Harrer, E.G., & Harrer, T. (2015). Identification of HLA-C restricted, HIV-1-specific CTL epitopes by peptide induced upregulation of HLA-C expression. Journal of Immunological Methods, 418, 9-18.
Keller, U., Hecht, M., Harrer, T., Harrer, E., Schuster, B., Fietkau, R., & Distel, L. (2015). NNRTI-based antiretroviral therapy may increase risk of radiation induced side effects in HIV-1-infected patients. Radiotherapy and Oncology, 116(2), 323-30.
Hueckelhoven, A., Etschel, J., Bergmann, S., Zitzelsberger, K., Müller-Schmucker, S., Harrer, E.G., & Harrer, T. (2015). Cross-Reactivity Between Influenza Matrix- and HIV-1 P17-Specific CTL-A Large Cohort Study. Jaids-Journal of Acquired Immune Deficiency Syndromes, 69(5), 528-35.
Chaurio Gonzalez, R., Munoz, L.E., Maueröder, C., Janko, C., Harrer, T., Fuernrohr, B.G.,... Berens, C. (2014). The Progression of Cell Death Affects the Rejection of Allogeneic Tumors in Immune-Competent Mice - Implications for Cancer Therapy. Frontiers in Immunology, 5, 560.

Last updated on 2019-24-04 at 10:28